Women Are Likelier to Drop Out after Early Political Loss
But the “persistence gap” in seeking elective office narrows with experience
Inviting White Workers to Join Diversity Initiatives May Increase Buy-In
Absent such a call, white workers may doubt they have a role
Could Costly Housing Bring Down Superstar Cities?
Stuart Gabriel’s research shows how a vibrant economic hub loses essential residents
When the Economy Goes South, Political Opinions Veer Right
A survey of 77 papers seeks better understanding of how crises shape beliefs and preferences
Some Corporate Mergers Hold Down Future Wages
Fewer employers = less competition for workers = smaller paychecks
What Drives LBO Fever? More Than Just Cheap Loans
Private equity investors weigh the total cost of capital — not just debt, but equity as well — when pursuing buyouts
How Antitrust Thinking on Hospital Mergers Has Been Forced to Evolve
Matt Schmitt’s research shows hospital prices rise after acquisitions, even where local competition is unchanged
Recession Recoveries Take Longer as Manufacturing Fades
Should stimulus be targeted toward displaced workers, rather than across the economy?
Workplace Empowerment Can Alter One’s View of Societal Authority
Chinese garment workers and U.S. university employees, worlds apart, react similarly when allowed a bit of self-determination
Faculty Q&A: MBA Students in Digital Detox, Committing Random Acts of Kindness
The empirical study of happiness, a growth area at business schools, enters the classroom
Good Information Alone Won’t Drive Financial Well-Being
A review of academic research finds the path to saving more and spending less often involves emotional prompts
How People Gather Information — or Don’t — to Make Decisions
Personal beliefs, especially among the less educated, often outweigh actual data
Do People Donate Money to Signal Their Intelligence?
Research suggests such a connection when donations are publicized
Pricing Algorithms Are Widely Used. Are They Legal?
A review of research comes as AI promises to turbocharge the tools and regulators allege they promote price-fixing
Mandated Disclosure of Clinical Trials Ignored — Especially for Competitive Drugs
Pharma companies less likely to disclose critical drug information than public institutions